Aducanumab is the new drug that may be the first ever to slow Alzheimer’s disease. It has been approved in the USA – and is highly controversial. Drug against Alzheimer’s approved in the USA – soon to be approved in Germany? For Alzheimer’s patients and their families, it is the only glimmer of hope in a desperate situation, for the manufacturer Biogen it is a billion-dollar business – for many scientists and doctors, aducanumab is above all one thing: too little research. Nevertheless, the U.S. Food and Drug Administration (FDA) granted approval for the novel active substance against Alzheimer’s disease…

COVID vaccines advance cancer research The mRNA vaccines were first used on a large scale in humans against the SARS-CoV-2 coronavirus. However, research on such vaccines was actually underway long before the corona pandemic. The global focus on this issue has given a huge boost to technology in this field. This could also lead to new vaccines against cancer in the foreseeable future. Expert Dr. Guido Wollmann explains the details. Dr. Guido Wollmann is head of the Christian Doppler Laboratory for Viral Immunotherapy at the Medical University of Innsbruck. His area of expertise is so-called oncolytic viruses. This special type…

An HIV diagnosis is still a shock for many people affected. Thanks to medication, a halfway normal life is now possible. But the fear of exclusion makes life difficult for many. Geneva (dpa) – When visitors are in the house, hide the medication. Making excuses to colleagues about regular check-ups with the doctor. In the parking lot in front of the HIV clinic, making sure no one sees you. This is the life of Anja, who learned in 2014 that she is HIV-positive. “It’s like a double life,” the 41-year-old tells Deutsche Presse-Agentur. Exactly 40 years ago, on June 5,…

There are rumors circulating on the Internet that you can protect yourself from corona with vitamin D medication. That sounds tempting – but a new study, praised for its methodology, has now investigated whether it is true. Low vitamin D status is not a risk factor for coronavirus infection, according to a new U.S. study. Although there seems to be such a connection when looking at the data alone, the researchers explain in the journal “Jama Open Network”. However, if influencing factors such as age, gender, ethnicity, body mass index, blood pressure, smoking status and place of residence are included,…

Would the coronavirus have triggered nothing more than a clear cold one day? That’s at least what one US scientist claims. Jennie Lavine, an infectiologist at Emory University in Atlanta, believes that in the future, the SARS-CoV-2 virus might lose its fear. The medical scientist predicts that Covid-19’s present causative agent will become an endemic pathogen, implying that it will occur in the future only locally. Vaccinations could become futile after that. However, because the progress of the Corona pandemic in the coming months is still completely uncertain, this prediction should be viewed with caution. Is Corona going to turn…

Effect of remdesivir deciphered In the search for effective drugs against the coronavirus SARS-CoV-2, attention fell early on the Ebola drug Remdesivir and in July this was the first drug to be approved in the EU against COVID-19. However, the drug only provides limited help, and a recent study has now revealed why Remdesivir cannot completely stop the virus from replicating. Researchers from the Max Planck Institute (MPI) for Biophysical Chemistry in Göttingen and the University of Würzburg have studied the effect of Remdesivir against the coronavirus and deciphered how the drug affects the reproduction of the virus and why…